Cargando…
Bone health in phenylketonuria: a systematic review and meta-analysis
Patients with Phenylketonuria (PKU) reportedly have decreased bone mineral density (BMD). The primary aim of this study was to perform a systematic review and meta-analysis to determine the extent and significance of low BMD in early treated patients with PKU. Secondary aims were to assess other bon...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340652/ https://www.ncbi.nlm.nih.gov/pubmed/25758373 http://dx.doi.org/10.1186/s13023-015-0232-y |
_version_ | 1782359047589068800 |
---|---|
author | Demirdas, Serwet Coakley, Katie E Bisschop, Peter H Hollak, Carla E M Bosch, Annet M Singh, Rani H |
author_facet | Demirdas, Serwet Coakley, Katie E Bisschop, Peter H Hollak, Carla E M Bosch, Annet M Singh, Rani H |
author_sort | Demirdas, Serwet |
collection | PubMed |
description | Patients with Phenylketonuria (PKU) reportedly have decreased bone mineral density (BMD). The primary aim of this study was to perform a systematic review and meta-analysis to determine the extent and significance of low BMD in early treated patients with PKU. Secondary aims were to assess other bone status indicators including bone turnover markers (BTM) and to define areas for future research. Two research teams (Amsterdam, Netherlands and Atlanta, USA) performed literature searches for articles reporting data on BMD, osteopenia and osteoporosis, BTM or other bone indicators in patients with PKU. Included articles were compared between research teams and assessed for quality and risk of bias. A total of 13 unique articles were included; 11/13 articles reported BMD including a total of 360 patients. Ten out of 11 articles found BMD was significantly lower in patients with PKU. Meta-analyses for total BMD (TBMD; 3 studies; n = 133), lumbar spine BMD (LBMD; 7 studies; n = 247), and femoral neck BMD (FBMD; 2 studies; n = 78) Z-scores were performed. Overall effect sizes were: TBMD −0.45 (95% CI −0.61, −0.28); LBMD −0.70 (95% CI −0.82, −0.57); FBMD −0.96 (95% CI −1.42, −0.49). Definitions of osteopenia and osteoporosis were highly heterogeneous between studies and did not align with World Health Organization standards and the International Society for Clinical Densitometry positions on BMD measurement. Despite individual study findings of low BMD indicating higher risk of osteoporosis, pooled available data suggest reduction in BMD is not clinically important when using standard definitions of low BMD. Results from studies evaluating BTM are inconclusive. Phenylalanine concentration, vitamin D, PTH, and nutrient intake do not correlate with BMD or BTM. We recommend forthcoming studies use standard definitions of low BMD to determine clinical implications of BMD Z-scores below 0, explore cause of low BMD in the subset of patients with low BMD for chronological age (Z-score < −2) and assess fracture risk in patients with PKU. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0232-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4340652 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43406522015-02-26 Bone health in phenylketonuria: a systematic review and meta-analysis Demirdas, Serwet Coakley, Katie E Bisschop, Peter H Hollak, Carla E M Bosch, Annet M Singh, Rani H Orphanet J Rare Dis Review Patients with Phenylketonuria (PKU) reportedly have decreased bone mineral density (BMD). The primary aim of this study was to perform a systematic review and meta-analysis to determine the extent and significance of low BMD in early treated patients with PKU. Secondary aims were to assess other bone status indicators including bone turnover markers (BTM) and to define areas for future research. Two research teams (Amsterdam, Netherlands and Atlanta, USA) performed literature searches for articles reporting data on BMD, osteopenia and osteoporosis, BTM or other bone indicators in patients with PKU. Included articles were compared between research teams and assessed for quality and risk of bias. A total of 13 unique articles were included; 11/13 articles reported BMD including a total of 360 patients. Ten out of 11 articles found BMD was significantly lower in patients with PKU. Meta-analyses for total BMD (TBMD; 3 studies; n = 133), lumbar spine BMD (LBMD; 7 studies; n = 247), and femoral neck BMD (FBMD; 2 studies; n = 78) Z-scores were performed. Overall effect sizes were: TBMD −0.45 (95% CI −0.61, −0.28); LBMD −0.70 (95% CI −0.82, −0.57); FBMD −0.96 (95% CI −1.42, −0.49). Definitions of osteopenia and osteoporosis were highly heterogeneous between studies and did not align with World Health Organization standards and the International Society for Clinical Densitometry positions on BMD measurement. Despite individual study findings of low BMD indicating higher risk of osteoporosis, pooled available data suggest reduction in BMD is not clinically important when using standard definitions of low BMD. Results from studies evaluating BTM are inconclusive. Phenylalanine concentration, vitamin D, PTH, and nutrient intake do not correlate with BMD or BTM. We recommend forthcoming studies use standard definitions of low BMD to determine clinical implications of BMD Z-scores below 0, explore cause of low BMD in the subset of patients with low BMD for chronological age (Z-score < −2) and assess fracture risk in patients with PKU. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0232-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-15 /pmc/articles/PMC4340652/ /pubmed/25758373 http://dx.doi.org/10.1186/s13023-015-0232-y Text en © Demirdas et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Demirdas, Serwet Coakley, Katie E Bisschop, Peter H Hollak, Carla E M Bosch, Annet M Singh, Rani H Bone health in phenylketonuria: a systematic review and meta-analysis |
title | Bone health in phenylketonuria: a systematic review and meta-analysis |
title_full | Bone health in phenylketonuria: a systematic review and meta-analysis |
title_fullStr | Bone health in phenylketonuria: a systematic review and meta-analysis |
title_full_unstemmed | Bone health in phenylketonuria: a systematic review and meta-analysis |
title_short | Bone health in phenylketonuria: a systematic review and meta-analysis |
title_sort | bone health in phenylketonuria: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340652/ https://www.ncbi.nlm.nih.gov/pubmed/25758373 http://dx.doi.org/10.1186/s13023-015-0232-y |
work_keys_str_mv | AT demirdasserwet bonehealthinphenylketonuriaasystematicreviewandmetaanalysis AT coakleykatiee bonehealthinphenylketonuriaasystematicreviewandmetaanalysis AT bisschoppeterh bonehealthinphenylketonuriaasystematicreviewandmetaanalysis AT hollakcarlaem bonehealthinphenylketonuriaasystematicreviewandmetaanalysis AT boschannetm bonehealthinphenylketonuriaasystematicreviewandmetaanalysis AT singhranih bonehealthinphenylketonuriaasystematicreviewandmetaanalysis |